594.02
                                            
            Medpace Holdings Inc stock is traded at $594.02, with a volume of 270.71K.
            It is up +1.56% in the last 24 hours and up +11.56% over the past month.
            Medpace is a late-stage contract research organization that provides full-service drug-development and clinical trial services to small and midsize biotechnology, pharmaceutical, and medical device firms. It also offers ancillary services, including bioanalytical laboratory services and imaging capabilities. The company was founded over 30 years ago and has more than 5,400 employees across 40 countries. Medpace is headquartered in Cincinnati, Ohio, and its operations are primarily based in the US, with additional presence in Europe, Asia, South America, Africa, and Australia. Cinven, a global private equity firm, acquired Medpace for $915 million in 2014 and exited its investment in 2018.
        
        See More
    Previous Close:
              $584.91
            Open:
              $584.9
            24h Volume:
                270.71K
            Relative Volume:
              0.80
            Market Cap:
                $16.69B
            Revenue:
              $2.23B
            Net Income/Loss:
              $418.30M
            P/E Ratio:
              44.18
            EPS:
                13.4469
            Net Cash Flow:
                $579.82M
            1W Performance:
              -0.41%
            1M Performance:
              +11.56%
            6M Performance:
                +94.69%
            1Y Performance:
              +85.89%
            Medpace Holdings Inc Stock (MEDP) Company Profile
Name
                  
                      Medpace Holdings Inc
                    
                Sector
                  Industry
                  Phone
                  
                      (513) 579-9911
                    
                Address
                  
                      5375 MEDPACE WAY, CINCINNATI, OH
                    
                Compare MEDP with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS | 
|---|---|---|---|---|---|---|
| 
                         
                          
                                MEDP
                            
                             
                        Medpace Holdings Inc 
                           | 
                    594.02 | 16.48B | 2.23B | 418.30M | 579.82M | 13.45 | 
| 
                         
                          
                                TMO
                            
                             
                        Thermo Fisher Scientific Inc 
                           | 
                    564.88 | 213.17B | 43.74B | 6.58B | 6.11B | 17.31 | 
| 
                         
                          
                                DHR
                            
                             
                        Danaher Corp 
                           | 
                    214.06 | 152.13B | 24.27B | 3.50B | 5.02B | 4.8589 | 
| 
                         
                          
                                IDXX
                            
                             
                        Idexx Laboratories Inc 
                           | 
                    722.94 | 50.36B | 4.04B | 985.66M | 774.34M | 12.01 | 
| 
                         
                          
                                A
                            
                             
                        Agilent Technologies Inc 
                           | 
                    144.69 | 41.49B | 6.79B | 1.22B | 1.09B | 4.2644 | 
| 
                         
                          
                                IQV
                            
                             
                        Iqvia Holdings Inc 
                           | 
                    213.88 | 36.86B | 15.90B | 1.28B | 2.21B | 7.2842 | 
Medpace Holdings Inc Stock (MEDP) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change | 
|---|---|---|---|
| Oct-02-25 | Downgrade | Barclays | Equal Weight → Underweight | 
| Sep-03-25 | Downgrade | Rothschild & Co Redburn | Buy → Neutral | 
| Jul-29-25 | Downgrade | UBS | Neutral → Sell | 
| Jul-23-25 | Downgrade | TD Cowen | Hold → Sell | 
| Jun-24-25 | Initiated | Barclays | Equal Weight | 
| Apr-22-25 | Downgrade | William Blair | Outperform → Mkt Perform | 
| Apr-14-25 | Downgrade | TD Cowen | Buy → Hold | 
| Mar-24-25 | Initiated | Leerink Partners | Market Perform | 
| Oct-23-24 | Downgrade | Robert W. Baird | Outperform → Neutral | 
| Oct-14-24 | Initiated | Redburn Atlantic | Buy | 
| Sep-27-24 | Downgrade | UBS | Buy → Neutral | 
| Sep-25-24 | Downgrade | Jefferies | Buy → Hold | 
| Aug-01-24 | Initiated | Truist | Hold | 
| May-29-24 | Initiated | TD Cowen | Buy | 
| May-28-24 | Initiated | Mizuho | Buy | 
| Apr-23-24 | Upgrade | Jefferies | Hold → Buy | 
| Mar-18-24 | Initiated | Deutsche Bank | Hold | 
| Feb-15-24 | Upgrade | UBS | Neutral → Buy | 
| Oct-24-23 | Upgrade | Robert W. Baird | Neutral → Outperform | 
| May-08-23 | Upgrade | Guggenheim | Neutral → Buy | 
| Oct-27-22 | Upgrade | UBS | Sell → Neutral | 
| Sep-07-22 | Initiated | UBS | Sell | 
| May-24-22 | Initiated | Guggenheim | Neutral | 
| Aug-05-21 | Resumed | Credit Suisse | Outperform | 
| Oct-02-20 | Upgrade | Truist | Hold → Buy | 
| Jun-08-20 | Upgrade | Robert W. Baird | Underperform → Neutral | 
| May-13-20 | Downgrade | Wolfe Research | Outperform → Peer Perform | 
| Apr-30-20 | Upgrade | SunTrust | Sell → Hold | 
| Apr-20-20 | Downgrade | Robert W. Baird | Neutral → Underperform | 
| Mar-17-20 | Downgrade | SunTrust | Hold → Sell | 
| Jan-27-20 | Downgrade | SunTrust | Buy → Hold | 
| Oct-31-18 | Upgrade | SunTrust | Hold → Buy | 
| Sep-17-18 | Initiated | SunTrust | Hold | 
| Jul-31-18 | Upgrade | William Blair | Mkt Perform → Outperform | 
| Nov-01-17 | Downgrade | William Blair | Outperform → Mkt Perform | 
| Sep-29-17 | Initiated | Raymond James | Mkt Perform | 
| Jul-10-17 | Downgrade | KeyBanc Capital Mkts | Overweight → Sector Weight | 
                    View All
                    
                  
                Medpace Holdings Inc Stock (MEDP) Latest News
How Medpace Holdings Inc. stock performs in high volatility marketsJuly 2025 Price Swings & Expert Curated Trade Setups - newser.com
How to monitor Medpace Holdings Inc. with trend dashboardsJuly 2025 Review & Real-Time Chart Breakout Alerts - newser.com
Can Medpace Holdings Inc. stock hit analyst price targetsTrade Volume Report & Low Risk Growth Stock Ideas - newser.com
Is Medpace Holdings Inc. stock bottoming outDollar Strength & Safe Capital Growth Trade Ideas - newser.com
Using RSI to spot recovery in Medpace Holdings Inc.July 2025 Sector Moves & Verified Short-Term Plans - newser.com
Is Medpace Holdings Inc. meeting your algorithmic filter criteriaMarket Trend Review & Growth Focused Stock Reports - newser.com
Does Medpace Holdings Inc. (01P) stock trade below intrinsic valueJuly 2025 Sentiment & Free Reliable Trade Execution Plans - newser.com
Is a relief rally coming for Medpace Holdings Inc. holdersWeekly Market Report & Growth Focused Stock Pick Reports - newser.com
Amalgamated Bank Sells 612 Shares of Medpace Holdings, Inc. $MEDP - MarketBeat
Envestnet Asset Management Inc. Has $32.30 Million Stock Position in Medpace Holdings, Inc. $MEDP - MarketBeat
Will Medpace Holdings Inc. (01P) stock outperform Dow JonesFed Meeting & Intraday High Probability Alerts - newser.com
Will Medpace Holdings Inc. (01P) stock sustain bullish trend into 2025July 2025 Volume & Verified High Yield Trade Plans - newser.com
How strong is Medpace Holdings Inc. (01P) stock earnings growthChart Signals & Community Trade Idea Sharing Platform - newser.com
Combining machine learning predictions for Medpace Holdings Inc.Earnings Recap Report & Daily Oversold Stock Bounce Ideas - newser.com
Why Medpace Holdings Inc. (01P) stock signals breakout potential2025 Top Gainers & Technical Confirmation Trade Alerts - newser.com
Medpace shares plunge 8% as 2025 guidance disappoints - MSN
Should I hold or sell Medpace Holdings Inc. stock in 2025July 2025 Earnings & Reliable Volume Spike Alerts - newser.com
Medpace Holdings (MEDP) Generated Strong Results in Q3 - MSN
This Insider Has Just Sold Shares In Medpace Holdings - simplywall.st
Retirement Systems of Alabama Reduces Stake in Medpace Holdings, Inc. $MEDP - MarketBeat
Combining price and volume data for Medpace Holdings Inc.2025 EndofYear Setup & Daily Risk Controlled Trade Plans - newser.com
How institutional buying supports Medpace Holdings Inc. stock2025 Fundamental Recap & Weekly High Return Forecasts - newser.com
What analysts say about Medpace Holdings Inc stockCup and Handle Formations & Explosive Profit Potential - earlytimes.in
Weiss Ratings Reiterates Buy (B) Rating for Medpace (NASDAQ:MEDP) - MarketBeat
How Medpace Holdings Inc. (01P) stock gains from tech spendingEarnings Recap Report & Advanced Swing Trade Entry Alerts - newser.com
How to forecast Medpace Holdings Inc. trends using time seriesWeekly Stock Report & Free High Return Stock Watch Alerts - newser.com
Volume spikes in Medpace Holdings Inc. stock – what they meanTrend Reversal & Verified Trade Idea Suggestions - newser.com
Medpace Holdings, Inc. $MEDP Stock Holdings Increased by Teacher Retirement System of Texas - MarketBeat
Medpace and Radiopharm Theranostics Advance Brain Metastases Imaging Study - MSN
Will Medpace Holdings Inc. stock return to pre crisis levelsJuly 2025 Macro Moves & High Conviction Buy Zone Alerts - newser.com
GWN Securities Inc. Takes $243,000 Position in Medpace Holdings, Inc. $MEDP - MarketBeat
Medpace Holdings, Inc. (MEDP) Analyst Insights, Price Targets & Recommendations - Yahoo! Finance Canada
Medpace Holdings Inc Stock (MEDP) Financials Data
Revenue
Net Income
Cash Flow
EPS
        Open in Yahoo
        |
        Open in Google
            |
            Open in Finviz
        |
        Open in MarketWatch
            |
            Open in EDGAR    
        |
        Open in Reuters
    
    
                Cap:
                 
                  | 
                Volume (24h):